Does Houlihan Lokey (HLI) Prioritize Capital Returns Over Earnings Momentum With Its Latest Results?

• Houlihan Lokey recently reported first-quarter 2026 net income of US$78 million, down from US$98 million a year earlier, while its Board declared a regular US$0.70 per-share quarterly dividend payable on September 15, 2026, and the company completed a US$321.54 million share repurchase program initiated in May 2022.
• Despite softer earnings, Houlihan Lokey retained its position as the leading financial services M&A adviser by transaction count in the first half of 2026, underscoring its deal-making volume against a competitive advisory backdrop.
• We’ll now examine how Houlihan Lokey’s sustained M&A deal leadership alongside softer quarterly earnings reshapes its investment narrative for investors.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Houlihan Lokey Investment Narrative Recap

To own Houlihan Lokey, you need to believe in its ability to convert leading M&A deal volume into resilient earnings, even when profits soften. The latest quarter’s lower net income and EPS highlight that earnings can be sensitive to deal timing, while the biggest near term risk remains cost pressure against any slowdown in global M&A activity. The recent news does not materially change that risk profile, but it does sharpen the focus on how efficiently the firm manages expenses.

Among the recent announcements, the completion of the US$321.54 million share repurchase program stands out alongside the regular US$0.70 dividend. Together, they show Houlihan Lokey continuing to return cash to shareholders even as quarterly earnings ease, which matters if you see capital returns as an important part of the thesis. How well this capital return posture can coexist with rising compensation and non compensation costs is closely tied to the company’s key catalysts.

Yet the more important thing investors should be aware of is how sustained cost inflation could...

Read the full narrative on Houlihan Lokey (it's free!)

Houlihan Lokey's narrative projects $3.6 billion revenue and $667.0 million earnings by 2029. This requires 12.7% yearly revenue growth and a $261.3 million earnings increase from $405.7 million.

Uncover how Houlihan Lokey's forecasts yield a $154.50 fair value, a 20% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts already expected more modest outcomes, with revenue of about US$3.4 billion and earnings of roughly US$601 million, and this softer quarter could reinforce their concern that secular changes in how clients use advisory services might pressure Houlihan Lokey’s fee pool over time. You should treat this as one more data point that may shift these narratives rather than something that settles the debate.

Explore 3 other fair value estimates on Houlihan Lokey - why the stock might be worth just $154.50!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Houlihan Lokey research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Houlihan Lokey research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Houlihan Lokey's overall financial health at a glance.

Curious About Other Options?

Our top stock finds are flying under the radar-for now. Get in early:

• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com